We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$6.3B
AUM Growth
+$328M
Cap. Flow
-$23.8M
Cap. Flow %
-0.38%
Top 10 Hldgs %
35.66%
Holding
131
New
2
Increased
27
Reduced
79
Closed
5

Top Buys

Rank Stock Value
1
FSS icon
Federal Signal
FSS
+$47.8M
2
DGII icon
Digi International
DGII
+$41.2M
3
HLIO icon
Helios Technologies
HLIO
+$28.2M
4
NEOG icon
Neogen
NEOG
+$22.3M
5
HLMN icon
Hillman Solutions
HLMN
+$13.9M

Sector Composition

Rank Sector Weight
1 Industrials 33.7%
2 Technology 31.56%
3 Healthcare 18.38%
4 Materials 6.19%
5 Consumer Discretionary 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYL icon
51
Tyler Technologies
TYL
$12.8B
$29.9M 0.47%
71,701
-1,021
-1% -$393K
WSO icon
52
Watsco Inc
WSO
$13.6B
$29.7M 0.47%
77,887
+405
+0.5% +$137K
POOL icon
53
Pool Corp
POOL
$7.5B
$29M 0.46%
77,485
-349
-0.4% -$119K
JKHY icon
54
Jack Henry & Associates
JKHY
$11.1B
$25.4M 0.4%
151,983
+128
+0.1% +$19.9K
HEI.A icon
55
HEICO Corp Class A
HEI.A
$37.2B
$24.8M 0.39%
176,610
-3,910
-2% -$524K
WST icon
56
West Pharmaceutical
WST
$24.9B
$22.3M 0.35%
58,342
-3,226
-5% -$1.15M
TECH icon
57
Bio-Techne
TECH
$11.3B
$20.8M 0.33%
254,507
-4,548
-2% -$366K
MTN icon
58
Vail Resorts
MTN
$5.3B
$19.9M 0.32%
79,050
-79
-0.1% -$19.3K
IT icon
59
Gartner
IT
$11.7B
$18M 0.29%
51,296
-4,639
-8% -$1.51M
BFAM icon
60
Bright Horizons
BFAM
$3.86B
$17.5M 0.28%
189,561
-2,760
-1% -$233K
CGNX icon
61
Cognex
CGNX
$11.3B
$15.3M 0.24%
272,597
-190
-0.1% -$9.83K
GWRE icon
62
Guidewire Software
GWRE
$14.2B
$14.6M 0.23%
192,057
+50
+0% +$3.83K
TFX icon
63
Teleflex
TFX
$5.98B
$14.5M 0.23%
59,919
+396
+0.7% +$99.2K
EVI icon
64
EVI Industries
EVI
$180M
$14.3M 0.23%
647,881
-29,840
-4% -$608K
LCII icon
65
LCI Industries
LCII
$2.65B
$13.5M 0.21%
106,906
+810
+0.8% +$92.7K
FIVN icon
66
FIVE9
FIVN
$2.54B
$11.4M 0.18%
138,366
+577
+0.4% +$38.7K
GNRC icon
67
Generac Holdings
GNRC
$12.5B
$6.75M 0.11%
45,262
-141
-0.3% -$16.1K
USPH icon
68
US Physical Therapy
USPH
$1.22B
$1.74M 0.03%
14,335
-1,790
-11% -$193K
NVEE
69
DELISTED
NV5 Global
NVEE
$1.66M 0.03%
60,092
ANSS
70
DELISTED
Ansys
ANSS
$1.62M 0.03%
4,913
-798
-14% -$253K
IIIV icon
71
i3 Verticals
IIIV
$342M
$1.53M 0.02%
66,802
PLMR icon
72
Palomar
PLMR
$3.45B
$1.51M 0.02%
26,062
KIDS icon
73
OrthoPediatrics
KIDS
$595M
$1.41M 0.02%
32,183
ONT
74
Onterris Inc
ONT
$580M
$1.39M 0.02%
33,035
BLFS icon
75
BioLife Solutions
BLFS
$1.7B
$1.38M 0.02%
62,262
-10,665
-15% -$225K

Similar funds

Conestoga Capital Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Conestoga Capital Advisors held 131 positions worth $6.3B, up 5.5% from $5.97B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Conestoga Capital Advisors's Q2 2023 filing shows 2 new, 27 increased, 79 reduced and 5 closed positions. Its largest new stake was Federal Signal: 865,065 shares worth $55.4M. The largest sale was Evoqua Water Technologies Corp. Common Stock, an estimated $94.6M.

By sector, the portfolio is most concentrated in Industrials at 34% of assets, down from 35% a quarter earlier, followed by Technology and Healthcare.

  • Conestoga Capital Advisors's largest Q2 2023 buy was Federal Signal: 865,065 shares worth $55.4M.
  • Conestoga Capital Advisors added most to Digi International in Q2 2023, an estimated $41.2M increase.
  • Conestoga Capital Advisors's biggest Q2 2023 reduction was Novanta, cutting an estimated $25.1M.
  • Conestoga Capital Advisors fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $94.6M.
  • Conestoga Capital Advisors's ten largest holdings make up 36% of its $6.3B portfolio in Q2 2023.
  • Conestoga Capital Advisors opened 2 new positions and closed 5 in Q2 2023.
  • Conestoga Capital Advisors's portfolio value rose 5.5% quarter-over-quarter to $6.3B.

Based on Conestoga Capital Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.